A carregar...
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System
OBJECTIVE: Lung cancer is an important health problem due to its high incidence and mortality. The treatment of metastatic disease improved after the molecular pathways of cancer came to be known. However, targeted therapy is unavailable to many patients treated within the Brazilian Sistema Único de...
Na minha lista:
| Publicado no: | J Bras Pneumol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Brasileira de Pneumologia e Tisiologia
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567624/ https://ncbi.nlm.nih.gov/pubmed/32490907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36416/1806-3756/e20180255 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|